|
CACHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69886327228141E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62736490949555E-12 |
| Normal-vs-Stage2 |
4.23080015465871E-10 |
| Normal-vs-Stage3 |
4.586400E-02 |
| Normal-vs-Stage4 |
2.299100E-03 |
| Stage1-vs-Stage2 |
9.264600E-01 |
| Stage1-vs-Stage3 |
2.905700E-02 |
| Stage1-vs-Stage4 |
6.695700E-02 |
| Stage2-vs-Stage3 |
3.479800E-02 |
| Stage2-vs-Stage4 |
2.917800E-02 |
| Stage3-vs-Stage4 |
5.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.27869999999586E-06 |
| Normal-vs-Asian |
9.539700E-02 |
| Caucasian-vs-AfricanAmerican |
1.621590E-01 |
| Caucasian-vs-Asian |
2.776200E-01 |
| AfricanAmerican-vs-Asian |
4.476600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35279581875625E-11 |
| Normal-vs-Female |
6.778100E-04 |
| Male-vs-Female |
6.32839999999968E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.79690000000111E-05 |
| Normal-vs-Extreme_Weight |
8.76898553769934E-12 |
| Normal-vs-Obese |
1.32699999988439E-07 |
| Normal-vs-Extreme_Obese |
1.021880E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.965580E-02 |
| Normal_Weight-vs-Obese |
4.969800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.193000E-01 |
| Extreme_Weight-vs-Obese |
1.919520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.192220E-01 |
| Obese-vs-Extreme_Obese |
8.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.340600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.61059999781443E-08 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.77950000000071E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.475630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.752000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.024400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.713700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.950600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.912000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.07179820574288E-11 |
| Normal-VS-Type2 PRCC |
1.86607000000061E-05 |
| Normal-VS-KIRP CIMP |
2.024500E-02 |
| Normal-VS-Unclassified PRCC |
3.611999999098E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.162910E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.52069999609972E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
1.254150E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.050400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.944360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.881800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53780000000658E-06 |
| Normal-vs-N1 |
2.396300E-02 |
| Normal-vs-N2 |
5.770400E-02 |
| N0-vs-N1 |
4.891900E-02 |
| N0-vs-N2 |
7.082800E-01 |
| N1-vs-N2 |
5.768400E-01 |
|
|
